Mario Gates |
Moscati 31, 00168 Rome, Italy. A clinical and pharmacologic review of skeletal muscle relaxants / relaxant for musculoskeletal conditions.Beebe FA, Barkin RL, Barkin S.New World Health, Division of Weider Communications Co. Cross-reactivity among drugs. In the scottie of compounds provoking non-allergic hypersensitivity reactions, cross-reactivity is explained by a com pharmacological characteristic, such as the inhibitory effect of non-steroidal anti-inflammatory drugs on cyclooxygenase-1 carisoprodol and the capability of muscle relaxants / relaxant or contrast media to release histamine through a non-immunologic mechanism. NSAIDs are used with much greater frequency than oral skeletal muscle relaxants / relaxant (SMRs) or opioids in the treatment of acute MSDs. The quality of design, hair removal execution, and reporting of trials for the treatment of MSDs needs to be improved.
Unfortunately, remarkably little sound science guides the choice of drug for the treatment of acute, uncomplicated MSDs, and the evaluation of efficacy of one agent over another is complicated by numerous factors. Only a limited number of high-quality, randomized, controlled trials (RCTs) provide evidence of the effectiveness of NSAIDs or SMRs in the treatment of acute, uncomplicated MSDs. In choosing alternative compounds, skin testing has been used in evaluating IgE-mediated cross-reactivity between penicillins and cephalosporins, as well as among muscle relaxants. In assessing T cell-mediated cross-reactivity among contrast media, corticosteroids, anticonvulsants antidepressants and heparins, delayed-reading intradermal tests and patch tests, together with lymphocyte transformation tests, can be performed. The precise relationship between musculoskeletal pain and spasm is not well understood. Trigger point injections are sometimes used with excellent results in the treatment of muscle spasm in myofacial pain and low-back pain. Muscle strains and other musculoskeletal disorders (MSDs) are a leading cause of work absenteeism. plan-b The decision to treat and choice of therapy are largely dictated by the duration, severity of symptoms, and degree of dysfunction.
Clinical problems.Romano A, Gueant-Rodriguez RM, Emelia M, Gaeta F, Caruso C, Gueant JL.Department pain relief of Internal Medicine and Geriatrics, UCSC-Allergy Unit, Unita di Allergologia, Complesso Integrato Columbus, Via G. Columbus.romano linet.itCross-reactivity among drugs is either mediated by immunologic mechanisms or not. The main clinical problem deriving from cross-reactivity among estradiol drugs is the compelling need to choose a potentially cross-reactive compound and, therefore, to assess cross-reactivity by diagnostic tests. Because of the limited sensitivity of in vivo and in vitro testing, the most prudent way of establishing the tolerability of a compound of the same group in patients who especially require one is a graded challenge when other allergologic tests are negative..
Clinical and physiologic studies show that pain tends to inhibit rather than facilitate reflex contractile activity. Inc., 202 Carnegie Center, cialis Suite 101, Princeton, NJ 08540, USA. Muscle pain, spasm, swell, and inflammation are symptomatic of strains. The dictum that pain induces spasm, which causes more pain, is not substantiated by critical analysis. The combination of an SMR and an NSAID or COX-2 inhibitor or the combination of SMR and tramadol/acetaminophen is superior to single agents alone. The painful muscle may not show EMG activity, and when there is, the timing and intensity tramadol often do not correlate with the pain. The former kind is usually explained by the presence of com antigenic determinants in the cross-reacting drugs.
Location: | Madrid, Spain |
Last access: | Friday, 13 March 2009, 02:07 PM (544 days 12 hours) |